9beta,10beta-epoxy Hexahydrocannabinol (exempt preparation)

9beta,10beta-epoxy Hexahydrocannabinol (exempt preparation) (Cay-44607) is an analytical reference standard categorized as a phytocannabinoid. 9beta,10beta-epoxy Hexahydrocannabinol induces catalepsy, hypothermia, hypolocomotion, and antinociception in the mouse tetrad assay for cannabimimetic activity. It is a potential metabolite of Delta9-THC (Cay-ISO60157, Cay-43003, Cay-42138) based on the published metabolism of Delta8-THC (Cay-ISO60158, Cay-41193, Cay-14042). At the time 9beta,10beta-epoxy hexahydrocannabinol (exempt preparation) (Cay-44607) was made available for purchase, specific metabolism data had not been published. Contact us if updated information on this molecule is now available. 9beta,10beta-epoxy Hexahydrocannabinol is regulated as a Schedule I product. 9beta,10beta-epoxy Hexahydrocannabinol (exempt preparation) (Cay-44607) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. InChI: InChI=1S/C21H30O3/c1-5-6-7-8-13-11-15(22)18-16(12-13)23-20(2,3)14-9-10-21(4)19(24-21)17(14)18/h11-12,14,17,19,22H,5-10H2,1-4H3/t14-,17-,19+,21-/m1/s1, InChIKey: VSQGBNUBIDZRPJ-BWZSVYRMSA-N, SMILES: CC1(C)[C@]2([H])CC[C@](O3)(C)[C@]3([H])[C@@]2([H])C4=C(O1)C=C(CCCCC)C=C4O